# EDGAR Filing Document

**Accession Number:** 0000822663
**File Stem:** 0001753926-25-001705
**Filing Date:** 2025-11
**Character Count:** 25795
**Document Hash:** d80d0d3b68f46b969b6fb2a99fc086ec
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001753926-25-001705.hdr.sgml**: 20251105

**ACCESSION NUMBER**: 0001753926-25-001705

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20251105

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251105

**DATE AS OF CHANGE**: 20251105

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INTERPARFUMS INC
- **CENTRAL INDEX KEY:** 0000822663
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 133275609
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-16469
- **FILM NUMBER:** 251454723

**BUSINESS ADDRESS:**
- **STREET 1:** 551 FIFTH AVE
- **STREET 2:** STE 1500
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10176
- **BUSINESS PHONE:** 2129832640

**MAIL ADDRESS:**
- **STREET 1:** 551 FIFTH AVENUE
- **STREET 2:** STE 1500
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10176

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INTER PARFUMS INC
- **DATE OF NAME CHANGE:** 19990715

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JEAN PHILIPPE FRAGRANCES INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? ipar-20251105.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): <u>November 5, 2025</u> 

<u>Interparfums, Inc.</u>

(Exact name of Registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware**  | **0-16469** | **13-3275609** |
| (State or other jurisdiction of<br>incorporation or organization) | Commission<br>File Number | (I.R.S. Employer<br>Identification No.) |

---

**<u>551 Fifth Avenue, New York, NY 10176</u>**

<u>(Address of Principal Executive Offices)</u>

**<u>212.983.2640</u>**

(Registrant's Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange** <br>**on which registered** |
| Common Stock, $.001 par value per share | IPAR | The Nasdaq Stock Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**<u>Item</u> <u>2.02</u> <u>Results of Operations and Financial Conditions</u>**

Certain portions of our press release dated November 5, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows**:**

* The 1<sup>st</sup>, 2<sup>nd</sup> (consisting of a table), 7<sup>th</sup> and 9<sup>th</sup> through 12<sup>th</sup> full paragraphs relating to the results of operations for the first nine (9) months and third quarter of 2025

* Portion of the 3<sup>rd</sup> paragraph relating to factors that affected the Company's topline growth 

* Portion of the 8<sup>th</sup> paragraph relating to results of operations for the third quarter and nine (9) months ended September 30, 2025

* The 4<sup>th</sup> and 5<sup>th</sup> paragraphs relating to sales by territory for the 2025 third quarter 

* The 13<sup>th</sup> paragraph relating to balance sheet, operating cash flow and working capital efficiency

* The 18<sup>th</sup> through 22<sup>nd</sup> paragraphs relating to the previously announced conference call for the 2025 third quarter results 

* The unaudited consolidated statements of income and consolidated balance sheets

**<u>Item 7.01 Regulation FD Disclosure</u>**

Certain portions of our press release dated November 5, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows**:** 

* The 3<sup>rd</sup> paragraph relating to the Company's planned innovation pipelines, rigorous advertising and promotion programs and portfolio evolution to impact potential sales for the fourth quarter of 2025 and into 2026

* The 6<sup>th</sup> paragraph relating to the Company's 2025 holiday sales through differentiated product offerings, targeting marketing initiatives and increased brand visibility

* The 14<sup>th</sup> paragraph relating to updating the projected guidance for the remainder of the 2025 year

* The 15<sup>th</sup> paragraph relating to the initial 2026 guidance issuance date

* The 25<sup>th</sup> paragraph relating to forward-looking information

* The balance of such press release not otherwise incorporated by reference in 2.02

**<u>Item 8.01 Other Events</u>**

* The 16<sup>th</sup> paragraph relating to dividends

* The 17<sup>th</sup> paragraph relating to the Company's plan to streamline its corporate structure whereby the wholly owned French subsidiary, Inter Parfums Holdings SA, will merge into Interparfums SA, the Company's French operating subsidiary, with Interparfums SA becoming the surviving entity in December 2025

**<u>Item</u> <u>9</u><u>.</u><u>0</u><u>1</u> <u>Financial Statements and Exhibits</u><u>.</u>**

---

| | |
|:---|:---|
| 99.1 | [Our press release dated November 5, 2025](ex991_1.htm) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: November 5, 2025

---

| | |
|:---|:---|
| Interparfums, Inc. | Interparfums, Inc. |
| By: | /s/ Michel Atwood |
|  | Michel Atwood, |
|  | Chief Financial Officer |

---

------

## Exhibit 99.1

**Exhibit 99.1**

![Image1](c8be991959a398c79301.jpg)

**<u>FOR IMMEDIATE RELEASE</u>**

**<u>INTERPARFUMS, INC. REPORTS</u> <u>2025</u> <u>THIRD</u> <u>QUARTER</u> <u>RESULTS</u>**

***FY2025 Guidance Refined to Reflect Market Dynamics***

New York, New York, November 5, 2025, Interparfums, Inc. (NASDAQ GS: IPAR) today reported results for the third quarter and nine months ended September 30, 2025.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Financial Highlights:** ($ in millions, except per share amounts)  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Three Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  | **Nine Months Ended September 30,**  |
| **Financial Highlights:** ($ in millions, except per share amounts)  | **2025** | **2024** | **% Change**  | **2025** | **2024** | **% Change**  |
| Net Sales  | $430  | $425  | +1%  | $1102  | $1091  | +1%  |
| Gross Margin  | 63.5%  | 63.9%  | (40) bps  | 64.4%  | 63.6%  | +80 bps  |
| Operating Income  | $109  | $106  | +2%  | $243  | $239  | +2%  |
| Operating Margin  | 25.3%  | 25.0%  | +30 bps  | 22.0%  | 21.9%  | +10 bps  |
| Net Income attributable to Interparfums, Inc.  | $66  | $62  | +6%  | $140  | $140  | --  |
| Diluted EPS  | $2.05  | $1.93  | +6%  | $4.36  | $4.34  | +0.5%  |
| &nbsp;&nbsp; *The average dollar/euro exchange rate for the 2025 third quarter was 1.17 compared to 1.10 in the 2024 third quarter leading to a positive 2% foreign exchange impact. For the first nine months of 2025, the average dollar/euro exchange rate was 1.12 compared to 1.09 in the first nine months of 2024, leading to a positive 1% foreign exchange impact.*  | &nbsp;&nbsp; *The average dollar/euro exchange rate for the 2025 third quarter was 1.17 compared to 1.10 in the 2024 third quarter leading to a positive 2% foreign exchange impact. For the first nine months of 2025, the average dollar/euro exchange rate was 1.12 compared to 1.09 in the first nine months of 2024, leading to a positive 1% foreign exchange impact.*  | &nbsp;&nbsp; *The average dollar/euro exchange rate for the 2025 third quarter was 1.17 compared to 1.10 in the 2024 third quarter leading to a positive 2% foreign exchange impact. For the first nine months of 2025, the average dollar/euro exchange rate was 1.12 compared to 1.09 in the first nine months of 2024, leading to a positive 1% foreign exchange impact.*  | &nbsp;&nbsp; *The average dollar/euro exchange rate for the 2025 third quarter was 1.17 compared to 1.10 in the 2024 third quarter leading to a positive 2% foreign exchange impact. For the first nine months of 2025, the average dollar/euro exchange rate was 1.12 compared to 1.09 in the first nine months of 2024, leading to a positive 1% foreign exchange impact.*  | &nbsp;&nbsp; *The average dollar/euro exchange rate for the 2025 third quarter was 1.17 compared to 1.10 in the 2024 third quarter leading to a positive 2% foreign exchange impact. For the first nine months of 2025, the average dollar/euro exchange rate was 1.12 compared to 1.09 in the first nine months of 2024, leading to a positive 1% foreign exchange impact.*  | &nbsp;&nbsp; *The average dollar/euro exchange rate for the 2025 third quarter was 1.17 compared to 1.10 in the 2024 third quarter leading to a positive 2% foreign exchange impact. For the first nine months of 2025, the average dollar/euro exchange rate was 1.12 compared to 1.09 in the first nine months of 2024, leading to a positive 1% foreign exchange impact.*  | &nbsp;&nbsp; *The average dollar/euro exchange rate for the 2025 third quarter was 1.17 compared to 1.10 in the 2024 third quarter leading to a positive 2% foreign exchange impact. For the first nine months of 2025, the average dollar/euro exchange rate was 1.12 compared to 1.09 in the first nine months of 2024, leading to a positive 1% foreign exchange impact.*  |

---

**Operational Commentary**

Jean Madar, Chairman & Chief Executive Officer of Interparfums, noted, "While the prestige and luxury fragrance category continues to perform well, broader macroeconomic factors, including retailer destocking, evolving consumer behavior, and tariff-related disruptions, moderated our topline growth. We remain confident that our strong innovation pipeline, supported by rigorous advertising and promotion programs, and ongoing portfolio evolution, will maintain sales momentum in the coming months and into 2026.

"Our two largest markets, North America and Western Europe, grew sales by 4% and 3%, respectively, on a year-to-date basis. Sales in Asia/Pacific were down 9%, due to distribution challenges in South Korea and India.

"With fragrance leading the beauty category in Central and South America, our sales increased 12% through the first nine months, fueled by the strength of Lacoste and Coach fragrance sales. Sales in Eastern Europe rose 6% compared with the first nine months of 2024, reflecting more normalized sales levels as last year's period was affected by sourcing constraints. The Middle East and Africa declined 16%, primarily due to the run-off of the Dunhill license, which was completed in August 2024. Excluding the impact of Dunhill, net sales in the Middle East and Africa declined 7%, as a result of ongoing conflict in the region and a smaller pool of prestige fragrance retailers."

------

Mr. Madar concluded, "Despite the slowing sales, we continue to invest in our brands to maximize engagement both in-store and online, leveraging the reach and performance across our e-commerce channels. We're positioned to capture sales in the final three months of the year as healthy consumer demand accelerates during the holiday gifting season, driven by differentiated product offerings, targeted marketing initiatives, and increased brand visibility."

**Financial Commentary**

Michel Atwood, Chief Financial Officer of Interparfums, noted, "For the first nine months of 2025, consolidated gross margin rose 80 basis points to 64.4%, driven by a favorable segment and brand mix in the nine months of the year. In the third quarter, however, it declined marginally by 40 basis points to 63.5% as favorable segment/channel/brand mix and pricing were not sufficient to fully offset the higher tariffs on our United States imports.

"SG&A expenses as a percentage of net sales were 38.2% and 42.4%, respectively, for the third quarter and first nine months of 2025 as compared to 38.9% and 41.8%, for the comparable periods in 2024, attributable to the phasing of advertising and promotional activities. These expenditures represented 15.3% and 16.9% of net sales for the third quarter and first nine months of 2025, compared to 15.7% and 16.6% for the respective periods of the prior year as we continue to invest in advertising and promotional activities ahead of our growth and in line with our expected sell-out.

"The key metrics mentioned resulted in operating margins of 25.3% and 22.0% for the third quarter and first nine months of 2025, respectively, as compared to 25.0% and 21.9% for the corresponding periods of 2024.

"Below the operating line, net income reflected other expenses of $7.7 million during the first nine months of 2025, compared to $7.1 million in the same period last year. Through September 30, 2025, we recorded $4.6 million in losses on foreign currency and a $2.5 million loss on marketable securities, while in the same period last year, there was a foreign currency loss of $3.1 million and a loss of $0.8 million on marketable securities.

"Our consolidated effective tax rate was 23.5% and 23.7% for the nine months ended September 30, 2025 and 2024, respectively as we benefited from a favorable net tax gain of $2 million in the third quarter following a positive outcome from prior year tax assessments.

"These factors contributed to our third quarter net income attributable to Interparfums, Inc. of $66 million, or $2.05 per diluted share, a 6% improvement over last year's third quarter. For the first nine months, net income was unchanged at $140 million, but up slightly on a diluted per share basis to $4.36.

"Our financial position remains healthy with $188 million in cash, cash equivalents and short-term investments, and working capital of $688 million. We generated $68 million in operating cash flow for the first nine months of 2025, up from $50 million a year ago, while working capital efficiency helped reduce cash usage to $134 million, compared to $147 million in the prior year."

------

**Guidance Update**

Mr. Atwood concluded, "Since November 2024, we have maintained our full-year 2025 guidance with confidence in our operational agility and disciplined execution. While our fundamentals remain strong with a healthy innovation pipeline, strong partnerships with global distributors and retailers, and a resilient consumer base, we are updating our 2025 guidance to reflect slower than anticipated growth through September of this year, amid ongoing macroeconomic uncertainty and moderating demand in several international markets outside the United States. We now expect $1.47 billion in sales, up 1% year-over-year, leading to diluted earnings per share of $5.12, flat compared to full-year 2024."

Interparfums plans to release its initial guidance for full-year 2026 on Tuesday, November 18, 2025, after the close of the market.

**Dividend**

The Company's regular quarterly cash dividend of $0.80 per share will be paid on December 31, 2025, to shareholders of record on December 15, 2025.

**Merger of French Subsidiaries**

In order to streamline our corporate structure, in December 2025, our wholly owned French subsidiary, Inter Parfums Holding SA ("IPH Subsidiary"), will merge into Interparfums SA, our French operating subsidiary, with Interparfums SA becoming the surviving entity. IPH Subsidiary did not conduct any business. We do not believe there will be any material impact to our shareholders, because before and after the merger our Company still own approximately 72% of Interparfums SA.

**Conference Call**

Management will host a conference call to discuss financial results and business operations beginning at 11:00 am ET on Thursday, November 6, 2025.

Interested parties may participate in the live call by dialing:

U.S. / Toll-free:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (877) 423-9820

International: (201) 493-6749

Participants are asked to dial-in approximately 10 minutes before the conference call is scheduled to begin.

A live audio webcast will also be available in the "Events" tab within the Investor Relations section of the Company's website at www.interparfumsinc.com, or by clicking here. The conference call will be available for webcast replay for approximately 90 days following the live event.

------

**About Interparfums, Inc.:**

Operating in the global fragrance business since 1982, Interparfums, Inc. produces and distributes a wide array of prestige fragrance and fragrance related products under license and other agreements with brand owners. The Company manages its business in two operating segments, European based operations, through its 72% owned subsidiary, Interparfums SA, and United States based operations, through wholly owned subsidiaries in the United States and Italy.

Our portfolio of prestige brands includes Abercrombie & Fitch, Anna Sui, Boucheron, Coach, Donna Karan/DKNY, Emanuel Ungaro, Ferragamo, Graff, GUESS, Hollister, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Longchamp, MCM, Moncler, Montblanc, Oscar de la Renta, Roberto Cavalli, and Van Cleef & Arpels, whose products are distributed in over 120 countries around the world through an extensive and diverse network of distributors. Interparfums, Inc. is also the registered owner of several trademarks including Lanvin, Rochas, and Solférino. Goutal and Off-White will join the Company's fragrance portfolio in 2026.

**Forward-Looking Statements**

Statements in this release which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions, and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions, or expectations will be achieved. In some cases, you can identify forward-looking statements by forward-looking words such as "anticipate, "believe", "could", "estimate", "expect", "intend", "may", "should", "will", and "would" or similar words. You should not rely on forward-looking statements, because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings "Forward Looking Statements" and "Risk Factors" in Interparfums' annual report on Form 10-K for the fiscal year ended December 31, 2024, and the reports Interparfums files from time to time with the Securities and Exchange Commission. Interparfums does not intend to and undertakes no duty to update the information contained in this press release.

---

| | | |
|:---|:---|:---|
| **Contact Information:** |  |  |
| Interparfums, Inc. | or | The Equity Group Inc. |
| Michel Atwood |  | Karin Daly |
| Chief Financial Officer |  | Investor Relations Counsel |
| (212) 983-2640 |  | (212) 836-9623 / kdaly@theequitygroup.com |
| www.interparfumsinc.com |  | www.theequitygroup.com |

---

See Accompanying Tables<br>

------

***INTERPARFUMS, INC. AND SUBSIDIARIES*** 

CONSOLIDATED BALANCE SHEETS

 *(In thousands except share and per share data)*

 *(Unaudited)*

---

| | | |
|:---|:---|:---|
|  ***ASSETS***  |  |  |
|  | **September 30, 2025**  | **December 31, 2024**  |
| **Current assets:**  |  |  |
| &nbsp;&nbsp; Cash and cash equivalents  | $110396 | $125433 |
| &nbsp;&nbsp; Short-term investments  | 77460 | 109311 |
| &nbsp;&nbsp; Accounts receivable, net  | 363624 | 274705 |
| &nbsp;&nbsp; Inventories  | 388302 | 371920 |
| &nbsp;&nbsp; Receivables, other  | 10369 | 6122 |
| &nbsp;&nbsp; Other current assets  | 40587 | 27035 |
| &nbsp;&nbsp; Income taxes receivable  | —  | 306 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current assets  | 990738 | 914832 |
| **Property, equipment and leasehold improvements, net**  | 186206 | 153773 |
| **Right-of-use assets, net**  | 24558 | 24603 |
| **Trademarks, licenses and other intangible assets, net**  | 328220 | 282484 |
| **Deferred tax assets**  | 15262 | 17034 |
| **Other assets**  | 19666 | 18535 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total assets**  | $1564650 | $1411261 |
| &nbsp;&nbsp;&nbsp;  ***LIABILITIES AND EQUITY***  |  |  |
| **Current liabilities:**  |  |  |
| &nbsp;&nbsp; Loans payable - banks  | $9393 | $8311 |
| &nbsp;&nbsp; Current portion of long-term debt  | 56901 | 41607 |
| &nbsp;&nbsp; Current portion of lease liabilities  | 6193 | 6087 |
| &nbsp;&nbsp; Accounts payable – trade  | 66985 | 91049 |
| &nbsp;&nbsp; Accrued expenses  | 152624 | 172758 |
| &nbsp;&nbsp; Income taxes payable  | 10677 | 12615 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total current liabilities  | 302773 | 332427 |
| **Long–term debt, less current portion**  | 139976 | 115734 |
| **Lease liabilities, less current portion**  | 17406 | 20455 |
| **Equity:**  |  |  |
| Interparfums, Inc. shareholders' equity:  |  |  |
| &nbsp;&nbsp; Preferred stock, $.001 par; authorized 1,000,000 shares; none issued  | —  | —  |
| &nbsp;&nbsp; Common stock, $.001 par; authorized 100,000,000 shares; outstanding 32,064,728 and 32,110,170 shares at September 30, 2025 and December 31, 2024, respectively  | 32 | 32 |
| &nbsp;&nbsp; Additional paid-in capital  | 109006 | 106702 |
| &nbsp;&nbsp; Retained earnings  | 826964 | 763240 |
| &nbsp;&nbsp; Accumulated other comprehensive loss  | (4780 ) | (72239 ) |
| &nbsp;&nbsp; Treasury stock, at cost, 8,960,587 and 9,981,665 shares at September 30, 2025 and December 31, 2024, respectively  | (60335 ) | (52864 ) |
| Total Interparfums, Inc. shareholders' equity  | 870887 | 744871 |
| &nbsp;&nbsp; Noncontrolling interest  | 233608 | 197774 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total equity  | 1104495 | 942645 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total liabilities and equity**  | $1564650 | $1411261 |

---

------

***INTERPARFUMS, INC. AND SUBSIDIARIES*** 

***CONSOLIDATED STATEMENTS OF INCOME***

*(In thousands except per share data)*

 *(Unaudited)* 

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended**  | **Three Months Ended**  | **Nine Months Ended**  | **Nine Months Ended**  |
|  | **September 30,**  | **September 30,**  | **September 30,**  | **September 30,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| **Net sales**  | $429579 | $424629 | $1102334 | $1090821 |
| **Cost of sales**  | 156762 | 153469 | 392451 | 396519 |
| **Gross margin**  | 272817 | 271160 | 709883 | 694302 |
| **Selling, general and administrative expenses**  | 164261 | 165166 | 467074 | 455506 |
| **Income from operations**  | 108556 | 105994 | 242809 | 238796 |
| Other expenses (income):  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Interest expense  | 2305 | 1978 | 5637 | 5726 |
| &nbsp;&nbsp;&nbsp; Loss on foreign currency  | 2215 | 3355 | 4576 | 3085 |
| &nbsp;&nbsp;&nbsp; Interest and investment (income) loss  | (2547 ) | 254 | (1199 ) | (1690 ) |
| &nbsp;&nbsp;&nbsp; Other (income) loss  | (978 ) | 1 | (1302 ) | (35 ) |
| **Nonoperating Income (Expense)**  | 995 | 5588 | 7712 | 7086 |
| **Income before income taxes**  | 107561 | 100406 | 235097 | 231710 |
| Income taxes  | 24282 | 23571 | 55218 | 54974 |
| **Net income**  | 83279 | 76835 | 179879 | 176736 |
| &nbsp;&nbsp;&nbsp; Less: Net income attributable to the noncontrolling interest  | 17470 | 14576 | 39590 | 36606 |
| **Net income attributable to Interparfums, Inc.**  | $65809 | $62259 | $140289 | $140130 |
| **Earnings per share:**  |  |  |  |  |
| **Net income attributable to Interparfums, Inc. common shareholders:**  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Basic  | $2.05 | $1.94 | $4.37 | $4.37 |
| &nbsp;&nbsp;&nbsp; Diluted  | $2.05 | $1.93 | $4.36 | $4.34 |
| **Weighted average number of shares outstanding:**  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Basic  | 32113 | 32026 | 32114 | 32030 |
| &nbsp;&nbsp;&nbsp; Diluted  | 32149 | 32266 | 32158 | 32266 |
| **Dividends declared per share**  | $0.80 | $0.75 | $2.40 | $2.25 |

---

------